Senseonics (SENS) Stock: Buy, Sell, or Hold?
SENS - Senseonics Holdings, Inc.
$8.19
0.18 (2.19%)
▲
5d:
-8.18%
30d:
-16.25%
90d:
+68.53%
WAIT
LOW Confidence
Analysis Updated: Oct 19, 2026 12:00 AM ET
Earnings: Nov 04, 2026
14d
Get Alerted When SENS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: SENS shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: SENS shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: SENS is currently trading at $8.19, which is considered oversold relative to its 30-day fair value range of $8.55 to $10.05.
Technical Outlook: Technically, SENS is in a strong uptrend. Immediate support is located at $7.75, while resistance sits at $10.55.
Market Sentiment: The stock scores a mixed 43/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. In the options market, Implied Volatility is low (1th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $13.67 (+70.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, SENS is in a strong uptrend. Immediate support is located at $7.75, while resistance sits at $10.55.
Market Sentiment: The stock scores a mixed 43/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. In the options market, Implied Volatility is low (1th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $13.67 (+70.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$8.55 -
$10.05
Company Quality Score
43/100
(HOLD)
Options IV Signal
1th percentile
(COMPLACENCY WARNING)
Volume Confirmation
HIGH
Confidence Score
86.2%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Options cheap (IV 1th percentile)
- NEUTRAL: Mixed technical signals (43/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 70.5% below Wall St target ($13.67)
- WARNING: Composite score 43/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$8.55 -
$10.05
Current vs Trading Range
OVERSOLD
Expected Move (7 Days)
±$0.78
(9.5%)
Support & Resistance Levels
Support Level
$7.75
Resistance Level
$10.55
Current Trend
Strong Uptrend
Technical data as of
Oct 19, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-4.10
Wall Street Target
$13.67
(+70.5%)
Revenue Growth (YoY)
117.8%
Profit Margin
-225.3%
Share & Embed Analysis
Last updated: October 20, 2026 10:28 AM ET
Data refreshes hourly during market hours. Next update: 11:28 AM
Data refreshes hourly during market hours. Next update: 11:28 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SENS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DXCM
DexCom Inc |
STRONG BUY
29 analysts |
$96 | 54 HOLD |
|
EW
Edwards Lifesciences Corp |
STRONG BUY
29 analysts |
$102 | 58 HOLD |
|
ABT
Abbott Laboratories |
STRONG BUY
28 analysts |
$121 | 54 HOLD |
|
SYK
Stryker Corporation |
STRONG BUY
29 analysts |
$363 | 43 HOLD |
|
MDT
Medtronic PLC |
BUY
29 analysts |
$105 | 41 HOLD |
